Verition Fund Management’s Estee Lauder EL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.3M | Buy |
460,213
+215,103
| +88% | +$17.4M | 0.18% | 106 |
|
|
2026
Q1 | $17.6M | Buy |
245,110
+221,764
| +950% | +$22.7M | 0.11% | 171 |
|
|
2025
Q4 | $2.44M | Sell |
23,346
-31,361
| -57% | -$3.04M | 0.01% | 1426 |
|
|
2025
Q3 | $4.82M | Sell |
54,707
-118,984
| -69% | -$10.6M | 0.02% | 1199 |
|
|
2025
Q2 | $14M | Buy |
173,691
+131,143
| +308% | +$8.44M | 0.06% | 361 |
|
|
2025
Q1 | $2.81M | Sell |
42,548
-22,335
| -34% | -$1.62M | 0.01% | 1330 |
|
|
2024
Q4 | $4.86M | Buy |
64,883
+31,392
| +94% | +$2.48M | 0.02% | 904 |
|
|
2024
Q3 | $3.34M | Buy |
33,491
+19,552
| +140% | +$1.85M | 0.02% | 1119 |
|
|
2024
Q2 | $1.48M | Sell |
13,939
-4,501
| -24% | -$590K | 0.01% | 1443 |
|
|
2024
Q1 | $2.84M | Buy |
18,440
+4,921
| +36% | +$698K | 0.02% | 1013 |
|
|
2023
Q4 | $1.98M | Buy |
13,519
+137
| +1% | +$18.2K | 0.02% | 852 |
|
|
2023
Q3 | $1.93M | Buy |
13,382
+1,397
| +12% | +$233K | 0.02% | 800 |
|
|
2023
Q2 | $2.35M | Sell |
11,985
-647
| -5% | -$137K | 0.03% | 610 |
|
|
2023
Q1 | $3.11M | Buy |
+12,632
| New | +$3.21M | 0.04% | 529 |
|
|
2022
Q4 | – | Sell |
-9,527
| Closed | -$2.13M | – | 2309 |
|
|
2022
Q3 | $2.06M | Buy |
9,527
+4,679
| +97% | +$1.19M | 0.02% | 880 |
|
|
2022
Q2 | $1.24M | Buy |
4,848
+2,763
| +133% | +$701K | 0.02% | 918 |
|
|
2022
Q1 | $567K | Sell |
2,085
-327
| -14% | -$98.4K | 0.01% | 1836 |
|
|
2021
Q4 | $893K | Sell |
2,412
-3,676
| -60% | -$1.25M | 0.01% | 1368 |
|
|
2021
Q3 | $1.83M | Buy |
+6,088
| New | +$1.99M | 0.02% | 699 |
|
|
2021
Q2 | – | Sell |
-1,350
| Closed | -$393K | – | 1947 |
|
|
2021
Q1 | $393K | Buy |
+1,350
| New | +$370K | ﹤0.01% | 978 |
|
|
2020
Q3 | – | Sell |
-4,398
| Closed | -$830K | – | 1141 |
|
|
2020
Q2 | $830K | Buy |
+4,398
| New | +$786K | 0.03% | 465 |
|
|
2019
Q2 | – | Sell |
-2,500
| Closed | -$414K | – | 1141 |
|
|
2019
Q1 | $414K | Buy |
+2,500
| New | +$367K | 0.02% | 725 |
|
|
2018
Q3 | – | Sell |
-7,723
| Closed | -$1.1M | – | 1295 |
|
|
2018
Q2 | $1.1M | Buy |
+7,723
| New | +$1.14M | 0.07% | 368 |
|
|
2018
Q1 | – | Sell |
-17,342
| Closed | -$2.21M | – | 1170 |
|
|
2017
Q4 | $2.21M | Buy |
17,342
+4,795
| +38% | +$576K | 0.2% | 89 |
|
|
2017
Q3 | $1.35M | Buy |
+12,547
| New | +$1.29M | 0.11% | 197 |
|
|
2017
Q1 | – | Sell |
-2,886
| Closed | -$221K | – | 1236 |
|
|
2016
Q4 | $221K | Buy |
+2,886
| New | +$235K | 0.02% | 991 |
|
|
2016
Q3 | – | Sell |
-5,679
| Closed | -$517K | – | 1178 |
|
|
2016
Q2 | $517K | Buy |
+5,679
| New | +$530K | 0.07% | 372 |
|
|
2015
Q2 | – | Sell |
-5,974
| Closed | -$497K | – | 642 |
|
|
2015
Q1 | $497K | Buy |
+5,974
| New | +$470K | 0.06% | 109 |
|
|
2014
Q4 | – | Sell |
-8,470
| Closed | -$633K | – | 438 |
|
|
2014
Q3 | $633K | Buy |
+8,470
| New | +$637K | 0.09% | 183 |
|
|
2013
Q4 | – | Sell |
-3,319
| Closed | -$232K | – | 549 |
|
|
2013
Q3 | $232K | Buy |
+3,319
| New | +$225K | 0.04% | 410 |
|
Other funds holding EL
Verition Fund Management's EL Position: Q2 2026 in Review
Verition Fund Management increased its Estee Lauder (EL) stake by 88% in Q2 2026, buying an estimated $17.4M and bringing the position to 460,213 shares worth $36.3M. The position accounts for 0.18% of the portfolio, ranked #106.
Verition Fund Management first reported a position in EL in Q3 2013 and has held it in 30 quarters since. 823 funds tracked by Wall St. Rank hold EL as of Q2 2026.
- Verition Fund Management held 460,213 shares of Estee Lauder worth $36.3M as of Q2 2026.
- Verition Fund Management bought 215,103 Estee Lauder shares in Q2 2026, an estimated $17.4M.
- Estee Lauder made up 0.18% of Verition Fund Management's portfolio in Q2 2026, its #106 holding.
- Verition Fund Management first reported a position in Estee Lauder in Q3 2013 and has held it in 30 quarters since.
- 823 funds tracked by Wall St. Rank held Estee Lauder as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.